Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Honda, Kazufumi ^a,l   Kobayashi, Michimoto ^b   Okusaka, Takuji ^c   Rinaudo, Jo Ann ^d   Huang, Ying ^e   Marsh, Tracey ^e   Sanada, Mitsuaki ^b   Sasajima, Yoshiyuki ^b   Nakamori, Shoji ^f   Shimahara, Masashi ^g   Ueno, Takaaki ^g   Tsuchida, Akihiko ^h   Sata, Naohiro ⁱ   Ioka, Tatsuya ^j   Yasunami, Yohichi ^k   Kosuge, Tomoo ^c   Miura, Nami ^a   Kamita, Masahiro ^a   Sakamoto, Takako ^b   Shoji, Hirokazu ^a   Jung, Giman ^b   Srivastava, Sudhir ^d   Yamada, Tesshi ^a   more..

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d NATIONAL CANCER INSTITUTE   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f NATIONAL HOSPITAL ORGANIZATION   (Japan)

^g OSAKA MEDICAL COLLEGE   (Japan)

^h TOKYO MEDICAL UNIVERSITY   (Japan)

ⁱ JICHI MEDICAL UNIVERSITY   (Japan)

^j OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^k FUKUOKA UNIVERSITY   (Japan)

^l JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; APOLIPOPROTEIN A2; TUMOR MARKER;

ADULT; AGED; BLOOD; EARLY CANCER DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; RISK FACTOR;

ADULT; AGED; ANTIBODIES; APOLIPOPROTEIN A-II; BIOMARKERS, TUMOR; EARLY DETECTION OF CANCER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RISK FACTORS;

EID: 84946935362     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15921     Document Type: Article

References (24)

1. Marengo, E. & Robotti, E. Biomarkers for pancreatic cancer: Recent achievements in proteomics and genomics through classical and multivariate statistical methods. World journal of gastroenterology: WJG 20, 13325-13342, doi: 10.3748/wjg.v20.i37.13325 (2014).
2. Chang, M. C., Wong, J. M. & Chang, Y. T. Screening and early detection of pancreatic cancer in high risk population. World journal of gastroenterology: WJG 20, 2358-2364, doi: 10.3748/wjg.v20.i9.2358 (2014).
3. Poruk, K. E., Firpo, M. A., Adler, D. G. & Mulvihill, S. J. Screening for pancreatic cancer: why, how, and who? Annals of surgery 257, 17-26, doi: 10.1097/SLA.0b013e31825ffbfb (2013).
4. Honda, K. et al. Possible detection of pancreatic cancer by plasma protein profiling. Cancer research 65, 10613-10622, doi: 10.1158/0008-5472.CAN-05-1851 (2005).
5. Honda, K. et al. Altered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validation. PloS one 7, e46908, doi: 10.1371/journal.pone.0046908 (2012).
6. Honda, K. et al. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine. Japanese journal of clinical oncology 43, 103-109, doi: 10.1093/jjco/hys200 (2013).
7. Ehmann, M. et al. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Pancreas 34, 205-214, doi: 10.1097/01.mpa.0000250128.57026.b2 (2007).
8. Ono, M. et al. Prolyl 4-hydroxylation of alpha-fibrinogen: a novel protein modification revealed by plasma proteomics. The Journal of biological chemistry 284, 29041-29049, doi: 10.1074/jbc.M109.041749 (2009).
9. Gao, X., Yuan, S., Jayaraman, S. & Gursky, O. Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL. Biochemistry 51, 4633-4641, doi: 10.1021/bi300555d (2012).
10. Pankhurst, G. et al. Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein. Journal of lipid research 44, 349-355, doi: 10.1194/jlr.M200256-JLR200 (2003).
11. Smith, L. E. et al. High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli. Journal of lipid research 53, 1708-1715, doi: 10.1194/jlr.D028043 (2012).
12. Matsugi, S. et al. Serum carboxypeptidase A activity as a biomarker for early-stage pancreatic carcinoma. Clinica chimica acta; international journal of clinical chemistry 378, 147-153, doi: 10.1016/j.cca.2006.11.010 (2007).
13. Shamamian, P. et al. Evaluation of pro-carboxypeptidase A and carboxypeptidase A as serologic markers for adenocarcinoma of the pancreas. HPB: the official journal of the International Hepato Pancreato Biliary Association 8, 451-457, doi: 10.1080/13651820600747907 (2006).
14. Koprowski, H., Herlyn, M., Steplewski, Z. & Sears, H. F. Specific antigen in serum of patients with colon carcinoma. Science 212, 53-55 (1981).
15. Goonetilleke, K. S. & Siriwardena, A. K. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 33, 266-270, doi: 10.1016/j.ejso.2006.10.004 (2007).
16. Locker, G. Y. et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 24, 5313-5327, doi: 10.1200/JCO.2006.08.2644 (2006).
17. Lennon, A. M. et al. The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? Cancer research 74, 3381-3389, doi: 10.1158/0008-5472.CAN-14-0734 (2014).
18. Feng, Z. et al. The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers. Clinical chemistry 59, 68-74, doi: 10.1373/clinchem.2012.185140 (2013).
19. Pepe, M. S. et al. Phases of biomarker development for early detection of cancer. Journal of the National Cancer Institute 93, 1054-1061 (2001).
20. Honda, K. et al. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. The Journal of cell biology 140, 1383-1393 (1998).
21. Ida, N., Sakurai, S., Hosoi, K. & Kunitomo, T. A highly sensitive enzyme-linked immunosorbent assay for the measurement of interleukin-8 in biological fluids. Journal of immunological methods 156, 27-38 (1992).
22. Mike, A. et al. Measurement of staphylokinase by enzyme-linked immunosorbent assay using monoclonal antibodies. Biological & pharmaceutical bulletin 17, 564-567 (1994).
23. Noro, R. et al. Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 24, 2594-2600, doi: 10.1093/annonc/mdt293 (2013).
24. Watabe, Y. et al. Copy number increase of ACTN4 is a prognostic indicator in salivary gland carcinoma. Cancer medicine 3, 613-622, doi: 10.1002/cam4.214 (2014).